[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Microencapsulation Market - Forecasts from 2019 to 2024

October 2019 | 109 pages | ID: M1284EB29C67EN
Knowledge Sourcing Intelligence LLP

US$ 3,950.00

E-mail Delivery (PDF), Hard Copy Mail Delivery, CD-ROM Mail Delivery

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
The microencapsulation market is projected to grow at a CAGR of 13.85% during the forecast period, reaching a total market size of US$27.209 billion in 2024 from US$12.494 billion in 2018. Microencapsulation is widely used in the healthcare and pharmaceutical sector for controlled drug delivery. Microencapsulation technologies are extensively used by pharmaceutical companies to mask the bitter taste or smell in drugs and to provide targeted delivery and controlled delivery. The demand for microencapsulated biomolecules is increasing in the pharmaceutical industry as well as the agriculture industry due to functions like effective and targeted delivery of the active ingredients. With the rising adoption of the technology by small and medium scale end-users, it is further expected to drive the demand in the microencapsulation market.

DRIVERS
    • Increasing demand for pharmaceuticals
    • Widespread applications of microencapsulation
          • The growing need to enhance product functionality
RESTRAINTS
    • High cost associated with the microencapsulated process
INDUSTRY UPDATES
    • In February 2019, Givaudan opened its first fragrance encapsulation center in Singapore for the Asia Pacific market.
The major players profiled in the Microencapsulation market include Watson Inc., AVEKA, Inc., MIKROCAPS, Capsularis, Givaudan, Koehler Innovative Solutions, Prinova, and Orbis Biosciences, Inc.

Segmentation

The microencapsulation market has been analyzed through the following segments:

By Technology
    • Spray
    • Emulsion
    • Coating
    • Dripping
By Application
    • Pharmaceuticals
    • Food and Beverage
    • Households and Personal Care
    • Agrochemicals
    • Others
By Geography

North America
    • USA
    • Canada
    • Mexico
South America
    • Brazil
    • Argentina
    • Others
Europe
    • Germany
    • France
    • United Kingdom
    • Spain
    • Others
Middle East and Africa
    • Israel
    • Saudi Arabia
    • Others
Asia Pacific
    • China
    • Japan
    • South Korea
    • India
    • Others
1. INTRODUCTION

1.1. Market Overview
1.2. Market Definition
1.3. Scope of the Study
1.4. Currency
1.5. Assumptions
1.6. Base, and Forecast Years Timeline

2. RESEARCH METHODOLOGY

2.1. Research Design
2.2. Secondary Sources

3. EXECUTIVE SUMMARY

4. MARKET DYNAMICS

4.1. Market Segmentation
4.2. Market Drivers
4.3. Market Restraints
4.4. Market Opportunities
4.5. Porter’s Five Force Analysis
  4.5.1 Bargaining Power of Suppliers
  4.5.2 Bargaining Power of Buyers
  4.5.3 Threat of New Entrants
  4.5.4 Threat of Substitutes
  4.5.5 Competitive Rivalry in the Industry
4.6. Life Cycle Analysis - Regional Snapshot
4.7. Market Attractiveness

5. MICROENCAPSULATION MARKET BY TECHNOLOGY

5.1. Spray
5.2. Emulsion
5.3. Coating
5.4. Dripping

6. MICROENCAPSULATION MARKET BY APPLICATION

6.1. Pharmaceuticals
6.2. Food and Beverage
6.3. Households and Personal Care
6.4. Agrochemicals
6.5. Others

7. MICROENCAPSULATION MARKET BY GEOGRAPHY

7.1. North America
  7.1.1. USA
  7.1.2. Canada
  7.1.3. Mexico
7.2. South America
  7.2.1. Brazil
  7.2.2. Argentina
  7.2.3. Others
7.3. Europe
  7.3.1. Germany
  7.3.2. France
  7.3.3. United Kingdom
  7.3.4. Spain
  7.3.5. Others
7.4. Middle East and Africa
  7.4.1. Israel
  7.4.2. Saudi Arabia
  7.4.3. Others
7.5. Asia Pacific
  7.5.1. China
  7.5.2. Japan
  7.5.3. South Korea
  7.5.4. India
  7.5.5. Others

8. COMPETITIVE INTELLIGENCE

8.1. Competitive Benchmarking and Analysis
8.2. Recent Investment and Deals
8.3. Strategies of Key Players

9. COMPANY PROFILES

9.1. Watson Inc.
9.2. AVEKA, Inc.
9.3. MIKROCAPS
9.4. Capsularis
9.5. Givaudan
9.6. Koehler Innovative Solutions
9.7. Prinova
9.8. Orbis Biosciences, Inc.
LIST OF FIGURES
LIST OF TABLES


More Publications